XORTX Therapeutics Inc.
XRTX
$2.28
-$0.03-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.80% | -178.54% | 19.83% | -163.83% | -26.83% |
| Total Depreciation and Amortization | -2.84% | 0.81% | -4.27% | -5.46% | -0.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.89% | 88.45% | 6.44% | 64.14% | 55.34% |
| Change in Net Operating Assets | -1,226.79% | -49.80% | 187.84% | 602.16% | -17.64% |
| Cash from Operations | -65.84% | 12.99% | 24.74% | 27.80% | 30.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -696.18% | -654.41% | -658.35% | 22.37% | -81.94% |
| Cash from Investing | -696.18% | -654.41% | -658.35% | 22.37% | -81.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 11.83% | -15.34% | -28.55% | -41.41% | -56.07% |
| Issuance of Common Stock | 342.64% | 32.75% | -35.87% | 31.53% | -20.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -288.36% | -102.90% | -10.56% | -11.40% | 30.29% |
| Cash from Financing | 392.02% | 9.82% | -48.64% | 39.84% | -18.80% |
| Foreign Exchange rate Adjustments | -312.82% | 198.05% | 175.00% | -437.10% | 128.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.56% | 15.21% | -65.22% | 60.02% | 34.70% |